SmartX has garnered 200 million yuan ($29 million) in its Series B+ and C rounds from Vertex Ventures China, Tianjin Venture Capital and HUA Capital while Brosmed Medical has secured ‘tens of millions of US dollars’ in its Series C funding led by Hillhouse Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in